XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Millions
Total IBM Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
[1]
Total IBM Stockholders' Equity
Common Stock and Additional Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
[1]
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Non-Controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
[1]
Total
Balance at the Beginning of the Period at Dec. 31, 2019 $ (66) $ 20,841 $ 55,895 $ (66) $ 162,954 $ (169,413) $ (28,597) $ 144 $ (66) $ 20,985
Net income plus other comprehensive income/(loss):                    
Net income   2,536     2,536         2,536
Other comprehensive income/(loss)   (160)         (160)     (160)
Total comprehensive income/(loss)   2,377               2,377
Cash dividends paid - common stock   (2,890)     (2,890)         (2,890)
Common stock issued under employee plans   239 239             239
Purchases and sales of treasury stock under employee plans - net   50     24 26       50
Changes in noncontrolling interests               (7)   (7)
Balance at the End of the Period at Jun. 30, 2020   20,551 56,135   162,559 (169,386) (28,757) 137   20,688
Balance at the Beginning of the Period at Mar. 31, 2020   19,999 56,092   162,626 (169,437) (29,283) 129   20,128
Net income plus other comprehensive income/(loss):                    
Net income   1,361     1,361         1,361
Other comprehensive income/(loss)   527         527     527
Total comprehensive income/(loss)   1,888               1,888
Cash dividends paid - common stock   (1,450)     (1,450)         (1,450)
Common stock issued under employee plans   42 42             42
Purchases and sales of treasury stock under employee plans - net   72     22 50       72
Changes in noncontrolling interests               8   8
Balance at the End of the Period at Jun. 30, 2020   20,551 56,135   162,559 (169,386) (28,757) 137   20,688
Balance at the Beginning of the Period at Dec. 31, 2020   20,597 56,556   162,717 (169,339) (29,337) 129   20,727
Net income plus other comprehensive income/(loss):                    
Net income   2,280     2,280         2,280
Other comprehensive income/(loss)   1,685         1,685     1,685
Total comprehensive income/(loss)   3,965               3,965
Cash dividends paid - common stock   (2,924)     (2,924)         (2,924)
Common stock issued under employee plans   355 355             355
Purchases and sales of treasury stock under employee plans - net   (51)     13 (65)       (51)
Changes in noncontrolling interests               (4)   (4)
Balance at the End of the Period at Jun. 30, 2021   21,942 56,912   162,086 (169,404) (27,652) 125   22,067
Balance at the Beginning of the Period at Mar. 31, 2021   21,389 56,788   162,218 (169,360) (28,257) 124   21,513
Net income plus other comprehensive income/(loss):                    
Net income   1,325     1,325         1,325
Other comprehensive income/(loss)   605         605     605
Total comprehensive income/(loss)   1,930               1,930
Cash dividends paid - common stock   (1,467)     (1,467)         (1,467)
Common stock issued under employee plans   124 124             124
Purchases and sales of treasury stock under employee plans - net   (33)     11 (44)       (33)
Changes in noncontrolling interests               1   1
Balance at the End of the Period at Jun. 30, 2021   $ 21,942 $ 56,912   $ 162,086 $ (169,404) $ (27,652) $ 125   $ 22,067
[1] * Reflects the adoption of the FASB guidance on current expected credit losses. Refer to note 2, “Accounting Changes.”